Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
NNettavisen | ||
Older | ||
HHealthTalk | ||
European Penny Stocks To Consider In May 2026 As of late April 2026, European markets have been navigating a challenging landscape marked by geopolitical tensions and fluctuating economic indicators. Despite these hurdles, opportunities abound for investors willing to explore beyond the mainstream indices. Penny stocks, though often considered niche investments, can offer intriguing growth potential when they are backed by sound financial fundamentals. In this article, we will examine three European penny stocks that stand out for their... | ||
IInvestornytt | ||
European Penny Stocks To Watch In January 2026 The European markets have recently faced a downturn, with the pan-European STOXX Europe 600 Index and major national indices like France’s CAC 40 and Germany’s DAX experiencing declines amid renewed trade and geopolitical uncertainties. Despite these challenges, investors continue to explore opportunities beyond the well-known names, turning their attention to penny stocks. While often associated with smaller or newer companies, penny stocks can still provide significant value when backed by... | ||
3 European Penny Stocks With Market Caps Up To €1B As the pan-European STOXX Europe 600 Index edges closer to record highs, optimism about future earnings and economic prospects is creating a favorable backdrop for investors. Penny stocks, although an outdated term, continue to capture attention as they represent smaller or emerging companies with potential for significant growth. By focusing on those with strong financials and clear growth paths, investors can find opportunities in these often-overlooked segments of the market. | ||
European Penny Stocks To Watch In November 2025 Amidst renewed concerns over inflated AI stock valuations, European markets have experienced a downturn, with the pan-European STOXX Europe 600 Index declining by 2.21%. Despite these broader market challenges, investors continue to explore opportunities in lesser-known segments such as penny stocks. These stocks, often representing smaller or newer companies, offer a blend of affordability and growth potential that remains attractive for those seeking value beyond the mainstream indices. | ||
Spotlight On 3 European Penny Stocks With Market Caps Larger Than €20M As European markets experience a pullback from recent highs amid political turmoil and international trade tensions, investors are increasingly looking for opportunities in less traditional areas of the market. Penny stocks, while often considered a relic of past trading days, still offer intriguing prospects for growth by focusing on smaller or newer companies with solid financial foundations. This article highlights several European penny stocks that combine strong balance sheets with... | ||
Uncovering Opportunities: I.M.D. International Medical Devices And 2 More European Penny Stocks As the European market experiences a modest rise, with major indices like Italy's FTSE MIB and France's CAC 40 showing notable gains, investors are keenly observing opportunities amid stable interest rates set by the European Central Bank. In this context, penny stocks—despite their somewhat outdated moniker—continue to captivate those seeking potential growth in smaller or newer companies. These stocks can offer a blend of value and growth when supported by strong financial health, making... | ||
Hamlet BioPharma And 2 Other European Penny Stocks To Watch The European market has shown resilience, with the STOXX Europe 600 Index rising by 1.18% amid easing trade tensions and optimism over potential U.S. interest rate cuts. For investors looking beyond well-known names, penny stocks—often smaller or newer companies—remain an intriguing area of exploration despite the term's outdated connotations. These stocks can offer compelling opportunities when they possess strong financials and growth potential, as exemplified by Hamlet BioPharma and two... | ||
DDNB | ||